Cma Sat Guru
Cma Sat Guru
Cma Sat Guru
As per Profit & Loss Account actuals / estimates for the year ended / ending
2020 2021 2022 2023 2024 2025 2026 2027
M/s SAT GURU HEALTH CARE PRIVATE LIMITED
Estimated Projected Projected Projected Projected Projected Projected Projected
1. Gross sales - (i) Domestic sales 742.78 848.88 955.00 955.00 955.00 955.00 955.00 955.00
(ii) Trading sales
(iii) Other Revenue Income
- - - - - -
Total 742.78 848.88 955.00 955.00 955.00 955.00 955.00 955.00
2. Less excise duty 0.00 - - - - - - -
Deduct other items - - - - - - -
3. Net sales(item 1 - item 2) 742.78 848.88 955.00 955.00 955.00 955.00 955.00 955.00
4. % age rise (+) or fall (-) in net sales as compared to
previous year (annualised) #VALUE! 14.28% 12.50% 0.00% 0.00% 0.00% 0.00% 0.00%
5. Cost of sales
i) Raw materials(including stores & spares and 428.40 489.60 550.80 550.80 550.80 550.80 550.80 550.80
other items used in the process of manufacture
(a) Imported
(b) Indigenous 428.40 489.60 550.80 550.80 550.80 550.80 550.80 550.80
ii) Other spares - - - - - - - -
(a) Imported - - - - - - -
(b) Indigenous 0.00 - - - - - - -
iii)Power and fuel 13.66 15.60 17.56 17.56 17.56 17.56 17.56 17.56
iv) Direct labour(staff salay) 66.00 72.60 79.20 85.80 92.20 92.20 92.20 92.20
v) Other mfg. Expenses (Repairs, Maint & Insurance)) 2.80 3.20 3.60 4.00 4.40 5.00 5.00 5.00
vi) Depreciation 36.47 32.83 29.54 26.59 23.93 20.34 17.29 14.70
vii) SUB-TOTAL (i to vi) 547.33 613.83 680.70 684.75 688.89 685.90 682.85 680.26
viii) Add:Opening stocks-in-process/stores& spares 0.00 - - - - - - -
Sub-total 547.33 613.83 680.70 684.75 688.89 685.90 682.85 680.26
ix) Deduct:Closing stocks-in-process/stores& spares
x) Cost of Production 547.33 613.83 680.70 684.75 688.89 685.90 682.85 680.26
xi) Add : Opening stock of Finished goods 0.00 - - - -
Sub-total 547.33 613.83 680.70 684.75 688.89 685.90 682.85 680.26
xii) Deduct closing stock of Finished goods 0.00 - - -
xiii) SUB-TOTAL (Total cost of sales) 547.33 613.83 680.70 684.75 688.89 685.90 682.85 680.26
Gross Profit 195.45 235.05 274.30 270.25 266.11 269.10 272.15 274.74
6. Selling, general & adm. expenses 20.16 23.04 25.92 25.92 25.92 25.92 25.92 25.92
7. SUB-TOTAL (5+6) 567.49 636.87 706.62 710.67 714.81 711.82 708.77 706.18
8. Operating profit before interest(3-7) 175.29 212.01 248.38 244.33 240.19 243.18 246.23 248.82
9. Interest 44.05 41.49 35.34 29.19 23.04 16.90 10.76 4.61
10.Operating profit after interest(8-9) 131.24 170.52 213.04 215.14 217.15 226.28 235.47 244.21
11. (i) Add other non-operating income
(a) Interest / Discount Received - - - - - - -
(b) Miscellaneous Income
(c) Income from sale of Dolochar
(d) Previous Year Adjustments - - - - - - -
Sub-total (income) - - - - - - - -
(ii) Deduct other non-operating exp.
(a)Amount written off 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60
(b)Others INTEREST
(c) Loss on sale of assets
Sub-total(expenses) 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60
(iii) Net of other non-operating income/expenses (0.60) (0.60) (0.60) (0.60) (0.60) (0.60) (0.60) (0.60)
12. Profit before tax/loss {10+11(iii)} 130.64 169.92 212.44 214.54 216.55 225.68 234.87 243.61
13. Provision for taxes 39.17 50.94 63.69 64.32 65.32 66.32 67.32 68.32
14. Net profit/loss (12-13) 91.47 118.98 148.75 150.22 151.23 159.36 167.55 175.29
15. (a)Equity dividend paid - (Withdrawals)
(b) Dividend Rate 0% 0% 0% 0% 0% 0% 0% 0%
16. Retained profit (14-15) 91.47 118.98 148.75 150.22 151.23 159.36 167.55 175.29
17. Retained profit/Net profit (% age) 100% 100% 100% 100% 100% 100% 100% 100%
12.31% 14.02% 15.58% 15.73% 15.84% 16.69% 17.54% 18.36%
FORM - III
CURRENT LIABILITIES Estimated Projected Projected Projected Projected Projected Projected Projected
5. Provision for taxation 39.17 50.94 63.69 64.32 65.32 66.32 67.32 68.32
6. Dividend payable
a. Outstanding Expenses
Other Current Liabilities [Sub-total (B)] 39.17 50.94 63.69 64.32 65.32 66.32 67.32 68.32
10. Total Current Liabilities( total of 1 to 9 excl 1(iii)) 39.17 50.94 63.69 64.32 65.32 66.32 67.32 68.32
TERM LIABILITIES
13.Term loans(excld instalments payable within 1 yr.) 330.94 283.66 189.10 141.82 141.82 141.82 141.82 141.82
17. TOTAL TERM LIABILITIES 330.94 283.66 189.10 141.82 141.82 141.82 141.82 141.82
18. Total Outside Liabilities(item 10 +17) 370.11 334.60 252.79 206.14 208.14 210.14 212.14 214.14
NET WORTH
19.Ordinary share capital 204.41 231.92 261.69 263.16 264.17 272.30 280.49 288.23
20.General Reserve -
21.Capital Reserve -
24. NET WORTH 204.41 231.92 261.69 263.16 264.17 272.30 280.49 288.23
25. TOTAL LIABILITIES 574.52 566.52 514.48 469.30 472.31 482.44 492.63 502.37
FORM - III (Continued)
ANALYSIS OF BALANCE SHEET (AMOUNT IN : Rs.in Lacs)
M/s SAT GURU HEALTH CARE PRIVATE LIMITED
ASSETS 2020 2021 2022 2023 2024 2025 2026 2027
CURRENT ASSETS
Estimated Projected Projected Projected Projected Projected Projected Projected
26.Cash and bank balances 1.69 4.73 5.44 6.85 3.79 4.26 6.74 6.18
27.Investments(other than long term investments) - - - - - - - -
(i) Fixed Deposits( LC,BG,Margin )
(ii)Other Fixed deposits with bank
28.(i) Receivables other than defered & export 82.53 94.32 106.11 106.11 106.11 106.11 106.11 106.11
( including bills purchased and dicounted by banks) - - - - - - -
(ii)Export receivables(incld bills purchased & dis.by bank) - - - - - - -
29.Instalments of deferred receivables(due within 1 yr.) - -
30.Inventory: - - - - - - - -
(i) Raw materials(including stores & other items - - - - - - - -
used in the process of manufacture)
a)Imported - - -
b)Indigenous 0.00
(ii) Stocks-in-process -
(iii)Finished goods - - - - - - - -
(iv) Other consumable spares - - - - - - - -
a)Fuel & Oil
b)Indigenous
31.Advances to suppliers of raw materials 0.00 -
32.Advance payment of taxes - -
33.Other current assets - - - - - - - -
- stock of medicines
- Others ( ) Loans & advances
34. TOTAL CURRENT ASSETS(total of 26 to 33) 84.22 99.05 111.55 112.96 109.90 110.37 112.85 112.29
FIXED ASSETS
35.Gross Block(land & building,machinery,work-in-process) 451.77 451.77 451.77 451.77 451.77 451.77 451.77 451.77
36.Depreciation to date 36.47 69.30 98.84 125.43 149.36 169.70 186.99 201.69
37. NET BLOCK (35-36) 415.30 382.47 352.93 326.34 302.41 282.07 264.78 250.08
OTHER NON-CURRENT ASSETS
38.Investments/book debts/adv./deposits which are not 75.00 85.00 50.00 30.00 60.00 90.00 115.00 140.00
Current Assets
(i) a)Investments in subsidiary companies/affiliates
b)Others (amount enmarked for future expansion) - - - - - -
(ii)Advances to suppliers of capital goods & contractors
(iii)Inter unit A/c.
(iv)Others-Debtors >6 months -
-Security deposit
-Any other Non-Current deposits -
39.Non-consumables stores & spares
40.Other non-current assets incl.dues from directors 0.00 - - - - - -
41. TOTAL OTHER NON-CURR.ASSETS 75.00 85.00 50.00 30.00 60.00 90.00 115.00 140.00
42.Intangible assets(patents, goodwill, prelim. exp.
bad/doubtful expenses not provided for, etc.) 0.00 - -
43. TOTAL ASSETS (34+37+41+42) 574.52 566.52 514.48 469.30 472.31 482.44 492.63 502.38
44. TANGIBLE NET WORTH (24-42) 204.41 231.92 261.69 263.16 264.17 272.30 280.49 288.23
45. NET WORKING CAPITAL(17+24)-(37+41+42) : 45.05 48.11 47.86 48.64 44.58 44.05 45.53 43.97
46. Current Ratio 2.15 1.94 1.75 1.76 1.68 1.66 1.68 1.64
47. Total Outside Liabilities/ Tangible Net Worth 1.81 1.44 0.97 0.78 0.79 0.77 0.76 0.74
48. Total Term Liabilities/Tangible Net Worth 1.62 1.22 0.72 0.54 0.54 0.52 0.51 0.49
0.00 - 0.00 0.00 0.00 0.00 0.00 0.00
FORM - IV
Comparative statement of Current assets & Current Liabilities ( Amount in Lacs)
M/s SAT GURU HEALTH CARE PRIVATE LIMITED As per Balance sheet as at
I. CURRENT ASSETS 2020 2021 2022 2023 2024 2025 2026 2027
1. SOURCES
a) Net profit (after tax) 91.47 118.98 148.75 150.22 175.29 0.00 0.00 0.00
b) Depreciation 36.47 32.83 29.54 26.59 14.70 0.00 0.00 0.00
c) Increase in capital 0.00 27.51 29.77 1.47 25.07 0.00 0.00 0.00
d) Increase in term liabilities,including public deposits 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
e) Decrease in : i ) Fixed assets 0.00 0.00 0.00 0.00 0.00 451.77 451.77 451.77
ii) Other non-current assets 0.00 0.00 35.00 20.00 0.00 60.00 90.00 115.00
f) Others 0.00 0.00 0.00 0.00 0.00 1.00 2.00 3.00
g) TOTAL 127.94 179.32 243.06 198.28 215.06 512.77 543.77 569.77
2. USES
a) Net loss
b) Decrease in term liabilities,including public deposits 0.00 47.28 94.56 47.28 0.00 141.82 141.82 141.82
c) Increase in : i ) Fixed asset 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ii ) Depreciation adjustment 0.00 0.00 0.00 0.00 -61.56 149.36 169.70 186.99
iii) Other non-current assets 0.30 10.00 0.00 0.00 110.00 0.00 0.00 0.00
d) Dividend payment (withdrawal) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
e) Others #VALUE! 118.98 148.75 150.22 175.29 264.17 272.30 280.49
f) TOTAL #VALUE! 176.26 243.31 197.50 223.73 555.35 583.82 609.30
3. Long term surplus / deficit #VALUE! 3.06 -0.25 0.78 -8.67 -42.58 -40.05 -39.53
check 45.05 3.06 -0.25 0.78 -4.67 -44.58 -44.05 -45.53
4. Increase / Decrease in current assets* - 14.83 12.50 1.41 (0.67) ### ### ###
(as per details given below)
5. Increase / Decrease in current liabilities - 11.77 12.75 0.63 4.00 (65.32) (66.32) (67.32)
other then bank borrowings
6. Increase / Decrease in working capital gap - 3.06 (0.25) 0.78 (4.67) (44.58) (44.05) (45.53)
7. Net surplus(+) / deficit(-) #VALUE! 0.00 (0.00) (0.00) (4.00) 2.00 4.00 6.00
8. Increase / Decrease in Bank borrowings - - - - - - - -
INCREASE / DECREASE IN NET SALES 0.00 106.10 106.12 0.00 0.00 ### ### ###
*Break-up of (4) #VALUE! 0.00 (0.00) (0.00) (4.00) 2.00 4.00 6.00
i ) Increase / decrease in Raw materials - - - - - - - -
ii ) Increase / decrease in Stock -in-process - - - - - - - -
iii ) Increase / decrease in Finished goods - - - - - - - -
iv) Increase / decrease in Receivables (a) Domestic - 11.79 11.79 - - ### ### ###
(b) Export - - - - - - - -
v ) Increase / decrease in Stores & spares - - - - - - - -
vi) Increase / decrease in Other current assets - 3.04 0.71 1.41 (0.67) (3.79) (4.26) (6.74)
- 14.83 12.50 1.41 (0.67) ### ### ###
Assesment of Working Capital Requirements
Financial Indicators
0.00 2020 2021 2022 2023 2024 2025 2026 2027
M/s SAT GURU HEALTH CARE PRIVATE
LIMITED Estimated Projected Projected Projected Projected 0.00 0.00 0.00
1. Net Sales 742.78 848.88 955.00 955.00 955.00 955.00 955.00 955.00
1.a. Operating Profit 175.29 212.01 248.38 244.33 240.19 243.18 246.23 248.82
2. Profit Before Tax 130.64 169.92 212.44 214.54 216.55 225.68 234.87 243.61
2.a. PBT / Net sales( % ) 17.59 20.02 22.25 22.46 22.68 23.63 24.59 25.51
3. Profit After Tax 91.47 118.98 148.75 150.22 151.23 159.36 167.55 175.29
4. Paid Up Capital 204.41 231.92 261.69 263.16 264.17 272.30 280.49 288.23
4.a. Cash Accruals 127.94 151.81 178.29 176.81 175.16 179.70 184.84 189.99
5. Tangible Net Worth 204.41 231.92 261.69 263.16 264.17 272.30 280.49 288.23
6. Total Outside Liability 370.11 334.60 252.79 206.14 208.14 210.14 212.14 214.14
7. TOL / TNW 1.81 1.44 0.97 0.78 0.79 0.77 0.76 0.74
7.a. Adjusted TNW 204.41 231.92 261.69 263.16 264.17 272.30 280.49 288.23
7.b. TOL / Adj. TNW 1.81 1.44 0.97 0.78 0.79 0.77 0.76 0.74
8. Total Current Assets 84.22 99.05 111.55 112.96 109.90 110.37 112.85 112.29
8.a. Total Tangible Assets 574.52 566.52 514.48 469.30 472.31 482.44 492.63 502.38
9. PBT / TTA ( % ) 22.74% 29.99% 41.29% 45.71% 45.85% 46.78% 47.68% 48.49%
10. Operating Expenses 567.49 636.87 706.62 710.67 714.81 711.82 708.77 706.18
11. Operating Expenses / Net Sales ( % ) 76.40% 75.02% 73.99% 74.42% 74.85% 74.54% 74.22% 73.95%
12. Cost Of Sales / Net sales ( % ) 73.69% 72.31% 71.28% 71.70% 72.14% 71.82% 71.50% 71.23%
13. Depretiation 36.47 32.83 29.54 26.59 23.93 20.34 17.29 14.70
14. Interest 44.05 41.49 35.34 29.19 23.04 16.90 10.76 4.61
15. Net Working Capital 45.05 48.11 47.86 48.64 44.58 44.05 45.53 43.97
17. Inventory + Receivables 82.53 94.32 106.11 106.11 106.11 106.11 106.11 106.11
18. Assessed Bank Finance 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
19. PBDIT 211.16 244.24 277.32 270.32 263.52 262.92 262.92 262.92
20. PBDIT / Intt. 4.79 5.89 7.85 9.26 11.44 15.56 24.43 57.03
21. PBDIT / TTA 36.75 43.11 53.90 57.60 55.79 54.50 53.37 52.34
22. Purchases 428.40 489.60 550.80 550.80 550.80 550.80 550.80 550.80
23. Sundry Creditors 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
24. TOL / TNW 1.81 1.44 0.97 0.78 0.79 0.77 0.76 0.74
25. CA /CL 2.15 1.94 1.75 1.76 1.68 1.66 1.68 1.64
26. Bank Finance / TCA ( % ) - - - - - #DIV/0! #DIV/0! #DIV/0!
27. Gross Sales / Total Current Assets 8.82 8.57 8.56 8.45 8.69 8.65 8.46 8.50
28. Operating Profit / Net Sales ( % ) 23.60 24.98 26.01 25.58 25.15 25.46 25.78 26.05
29. Operating Profit / TTA ( % ) 30.51 37.42 48.28 52.06 50.85 50.41 49.98 49.53
30. Operating Profit / TNW ( % ) 85.75 91.42 94.91 92.84 90.92 89.31 87.79 86.33
31. Operating Profit / Gross Fixed Assets( % ) 38.80 46.93 54.98 54.08 53.17 53.83 54.50 55.08
EFFICIENCY RATIOS
1. Net Sales to TTA ( times) 1.29 1.50 1.86 2.03 2.02 1.98 1.94 1.90
2.PBT to TTA ( % ) 22.74 29.99 41.29 45.71 45.85 46.78 47.68 48.49
3. Operating costs to sales ( % ) 76.40 75.02 73.99 74.42 74.85 74.54 74.22 73.95
4. Bank Finance to TCA ( % ) - - - - - #DIV/0! #DIV/0! #DIV/0!
5. Inventory +Receivables to net sales ( days) 41 41 41 41 41 41 41 41
A. Assessed Bank Finance 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
B. CA /CL 2.15 1.94 1.75 1.76 1.68 1.66 1.68 1.64
C. TOL / TNW 1.81 1.44 0.97 0.78 0.79 0.77 0.76 0.74
D. PBDIT / Intt. 4.79 5.89 7.85 9.26 11.44 15.56 24.43 57.03
E. Net Profit / Net Sales ( % ) 12.31 14.02 15.58 15.73 15.84 16.69 17.54 18.36
F. (PBDIT / TTA) ROCE 36.75 43.11 53.90 57.60 55.79 54.50 53.37 52.34
G. (Inventory + Receivable)/Net Sales ( days ) 41 41 41 41 41 41 41 41
Inv/NS+Rec/GS (days) 41 41 41 41 41 41 41 41
2008 2009 2010 2011 2012 2013
Cross Checks
Audited Provisional Estimates ProjectionsProjectionsProjections
Difference in Balance Sheet (1) (2) (3) (4)
Diff between SIP in P& L and in Balance sheet 0.00 0.00 0.00 0.00 #VALUE! #VALUE!
Diff between FG in P& L and in Balance sheet 0.00 0.00 0.00 0.00 #VALUE! #VALUE!
Diff between Depre. in P& L and in Balance sheet 0.00 0.00 (61.56) #VALUE! #VALUE!
Diff between P& L Balane & Inc in Retained Earnings 148.75 150.22 175.29 #VALUE! #VALUE!
9 Funds borrowed from Group Cos 0.00 0.00 0.00 0.00 0.00
Directors/friends, etc
Net Profit to Net Sales (%) 19.43 21.85 24.08 24.30 27.35
Age of Inventory
4 Cost of Sales
a) Raw materials (incl. Stores) 428.40 489.60 550.80 550.80 550.80
* other spares Indigenous 0.00
* Indigenous 428.40 489.60 550.80 550.80 550.80
b) Scrap
c) Power and Fuel 0.00 0.00 0.00 0.00 0.00
d) Direct Expenses 66.00 72.60 79.20 85.80 92.20
e) Other Manf Exp. 2.80 3.20 3.60 4.00 5.00
f) Rent for lease rent 0.00
g) Depreciation 36.47 32.83 29.54 26.59 14.70
Sub-total 533.67 598.23 663.14 667.19 662.70
Add: Op. Stock in Process 0.00 0.00 0.00 0.00 0.00
Sub Total 533.67 598.23 663.14 667.19 662.70
Less: Cl. Stock in Process 0.00 0.00 0.00 0.00 0.00
Cost of Production (Sub-total) 533.67 598.23 663.14 667.19 662.70
Add: Op. Stock of Finished Goods 0.00 1.00 2.00 3.00 4.00
Sub Total 533.67 599.23 665.14 670.19 666.70
Less: Cl. Stock of Finished Goods 0.00 1.00 2.00 3.00 4.00
COST OF SALES 533.67 598.23 663.14 667.19 662.70
5 Gross Profit (3-4) 209.11 250.65 291.86 287.81 292.30
6 Interest 44.05 41.49 35.34 29.19 4.61
7 Selling, General & Admn. Expenses 20.16 23.04 25.92 25.92 25.92
Sub Total 64.21 64.53 61.26 55.11 30.53
8 Operating Profit 144.90 186.12 230.60 232.70 261.77
9 Other Income/Expenses
Add:Income 0.00 0.00 0.00 0.00 0.00
Less Expenses 0.60 0.60 0.60 0.60 0.60
Sub-total (+)/(-) (0.60) (0.60) (0.60) (0.60) (0.60)
10 Profit Before tax/Loss 144.30 185.52 230.00 232.10 261.17
Less: Provision for development Reb 0.00 0.00 0.00 0.00 0.00
Prior period items/Prliminary Exp. w/off
Less: Provision for withdrawal 0.00 0.00 0.00 0.00 0.00
Defferred Taxes 39.17 50.94 63.69 64.32 68.32
11 Net Profit (retained profit) 105.13 134.58 166.31 167.78 192.85
Net Profit (after tax) 105.13 134.58 166.31 167.78 192.85
Borrower's Name: M/s SKM CONCRETE ANNEXURE F/1
Following Year Following Year Following Year Following Year Following Year
LIABILITIES Estimated Projections Projections Projections Projections
2009 2010 2011 2012 2013
CURRENT LIABILITIES:
2 Short Term borrowing from Others 0.00 0.00 0.00 0.00 0.00
TERM LIABILITIES
16 Term Loans (repayable after 1 year) 330.94 283.66 189.10 141.82 141.82
NET WORTH
CURRENT ASSETS
b) Export receivables
b) Stocks in Process
FIXED ASSETS:
39 Gross Block Projected Fixed Assets A 451.77 451.77 451.77 451.77 451.77
Construction work in progress, etc.,)
Capital Work in Progress 0.00 0.00
1 SOURCES
Profit Before Tax 185.52 230.00 232.10 261.17
Add: Depreciation (net) 32.83 29.54 26.59 76.26
Investment Allowance
Gross Funds generated 218.35 259.54 258.69 337.43
Less Taxes paid/payable 0.00 0.00 0.00 0.00
dividend 50.94 63.69 64.32 68.32
Add: Preliminary Expenses
Prior period adjustments
A. NET FUNDS GENERATED 167.41 195.85 194.37 269.11
INCREASE IN
a) Capital (107.07) (136.54) (166.31) (167.78)
b) TL/Deb/Deb payment 0.00
c) Public Deposit 0.00 0.00 0.00 0.00
d) Other Term Liabilities 0.00 0.00 0.00 0.00
DECREASE IN
a) Fixed Assets 0.00 0.00 0.00 0.00
b) Intercorporate Investment
c) Other Non-current Assets 0.02 0.03 0.02 0.03
d) Intangible assets 0.00 0.00 0.00 0.00
B. SUB TOTAL (107.05) (136.51) (166.29) (167.75)
Increase in
a) Inventory 0.00 0.00 0.00 0.00
b) In receivables 11.79 11.79 0.00 0.00
c) Other Cur. Assets 3.04 0.71 1.41
Loss
Less: Inv. Allowance
Depreciation
3 SUMMARY
Diff in TNW
10.02 (34.97) (19.98) 106.03
Borrower's Name: M/s SKM CONCRETE
Projected domestic sales (Net sales) From 01.06.13 to 31.3.14 742.78 (10 Months) From 01.04.14 to 31.03.2015
Projected Export sales From 01.06.13 to 31.3.14
Classification of Industry T/C Following Year Following Year Following Year Following Year
Assumed Projections Projections Projections Projections
Norms 2010 2011 2012 2013
(Months) 1 2 3 3
I CURRENT ASSETS
* Raw materials imported 0.00 0.00 0.00 0.00
(Months consumption)
* Raw materials indigenous 0.00 0.00 0.00 0.00
(Months consumption) 0.00 0.00 0.00 0.00
* Other consumable spares 0.00 0.00 0.00 0.00
(Months consumption) #DIV/0! #DIV/0! #DIV/0! #DIV/0!
* Stocks in Process 0.00 0.00 0.00 0.00
(Months Cost of Production) 0.00 0.00 0.00 0.00
* Finished goods 0.00 0.00 0.00 0.00
(Months Cost of Sales) 0.00 0.00 0.00 0.00
* Receivables - Domestic 94.32 106.11 106.11 106.11
(Months Total sales) (1.33) (1.33) (1.33) (1.33)
* Receivables - Export
(Months Sales)
Advance to suppliers 0.00 0.00 0.00 0.00
Other current Assets 4.73 5.44 6.85 6.18
Total (I) 99.05 111.55 112.96 112.29
II CURRENT LIABILITIES
(Other than bank borrowings)
Creditors for Purchases 0.00 0.00 0.00 0.00
(Months purchase) 0.00 0.00 0.00 0.00
TL instalments 0.00 0.00 0.00 0.00
Advance from Customers 0.00 0.00 0.00 0.00
Accrured Expenses / Provisons 0.00 0.00 0.00 0.00
Statutory liabilities 0.00 0.00 0.00 0.00
Other current Liabilities, incl. Creditors for exp 50.94 63.69 64.32 68.32
Total (II) 50.94 63.69 64.32 68.32
III Working Capital Gap (I-II) 48.11 47.86 48.64 43.97
IV Actual/Projected Bank Borrowings 0.00 0.00 0.00 0.00
V Total Current Liabilities (II + IV) 50.94 63.69 64.32 68.32
VI Actual/Projected Net Working Capital (I-V) 48.11 47.86 48.64 43.97
VII Min. Stipulated Net Working Capital 12.03 11.97 12.16 10.99
(excl. Export Receivables)
VIII Item No III - Item VII 36.08 35.90 36.48 32.98
IX Item No III - Item VI 0.00 0.00 0.00 0.00
X Max. Permissible Bank Finance 0.00 0.00 0.00 0.00
(Item VIII or IX whichever is lower)
XI Excess Borrowings (VII-VI)
SECTION II - FINANCIAL PARAMETERS AND ASSESSMENT
1 FINANCIAL PERFORMANCE
Borrower's Name: M/s SKM CONCRETE
Following Year Following Year Following Year Following Year Following Year
Estimated Projections Projections Projections Projections
2009 2010 2011 2012 2013
Schedule F 10
SCHEDULE SHOWING COMPUTATION OF INTEREST & REPAYMENT SCHEDULE
ROI 14.50% Rs. in Lacs
Nos of
quarter Quarter
Year Qtr Loan Amount Repayment Balance Interest Interest p.a.
starting
1 2015 I 10.00 0.50 9.50 0.34 0.34 Apr-13
2 II 9.50 0.50 9.00 0.33 Jul-13
3 III 9.00 0.50 8.50 0.31 Oct-13
4 2016 IV 8.50 0.50 8.00 0.30 1.22 Jan-14
5 I 8.00 0.50 7.50 0.28 Apr-14
6 II 7.50 0.50 7.00 0.26 Jul-14
7 III 7.00 0.50 6.50 0.24 Oct-14
8 2017 IV 6.50 0.50 6.00 0.23 0.94 Jan-15
9 I 6.00 0.50 5.50 0.21 Apr-15
10 II 5.50 0.50 5.00 0.19 Jul-15
11 III 5.00 0.50 4.50 0.17 Oct-15
12 2018 IV 4.50 0.50 4.00 0.15 0.65 Jan-16
13 I 4.00 0.50 3.50 0.14 Apr-16
14 II 3.50 0.50 3.00 0.12 Jul-16
15 III 3.00 0.50 2.50 0.10 Oct-16
16 2019 IV 2.50 0.50 2.00 0.08 0.36 Jan-17
17 I 2.00 0.50 1.50 0.06 Apr-17
18 II 1.50 0.50 1.00 0.05 Jul-17
19 2020 III 1.00 0.50 0.50 0.03 0.09 Oct-17
20 IV 0.50 0.50 0.00 0.01 Jan-18
DEP